Subgroup‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination
Author:
Affiliation:
1. Department of Statistics Rice University Houston Texas
2. Department of Biostatistics MD Anderson Cancer Center Houston Texas
Funder
National Computational Infrastructure
National Institutes of Health
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology,Statistics and Probability
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.1891
Reference23 articles.
1. Design and Analysis of Phase I Clinical Trials
2. Cancer phase I clinical trials: efficient dose escalation with overdose control
3. Phase I clinical trial design in cancer drug development;Eisenhaiuer PJ;J Clin Trials,2000
4. Dose-finding in phase I clinical trials based on toxicity probability intervals
5. Adaptive dose modification for phase I clinical trials
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Personalized Dose‐Finding Algorithm Based on Adaptive Gaussian Process Regression;Pharmaceutical Statistics;2024-08-09
2. Adaptive Bayesian information borrowing methods for finding and optimizing subgroup-specific doses;Clinical Trials;2024-01-19
3. Adaptive phase I–II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies;Clinical Trials;2024-01-11
4. Bayesian Statistical Methods in Stem Cell Transplantation and Cellular Therapy;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024
5. A Multi-Armed Bayesian Ordinal Outcome Utility-Based Sequential Trial with a Pairwise Null Clustering Prior;Bayesian Analysis;2023-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3